cucumber
发表于 2025-3-21 17:28:19
书目名称Biology and Treatment of Leukemia and Bone Marrow Neoplasms影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0187667<br><br> <br><br>书目名称Biology and Treatment of Leukemia and Bone Marrow Neoplasms影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0187667<br><br> <br><br>书目名称Biology and Treatment of Leukemia and Bone Marrow Neoplasms网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0187667<br><br> <br><br>书目名称Biology and Treatment of Leukemia and Bone Marrow Neoplasms网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0187667<br><br> <br><br>书目名称Biology and Treatment of Leukemia and Bone Marrow Neoplasms被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0187667<br><br> <br><br>书目名称Biology and Treatment of Leukemia and Bone Marrow Neoplasms被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0187667<br><br> <br><br>书目名称Biology and Treatment of Leukemia and Bone Marrow Neoplasms年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0187667<br><br> <br><br>书目名称Biology and Treatment of Leukemia and Bone Marrow Neoplasms年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0187667<br><br> <br><br>书目名称Biology and Treatment of Leukemia and Bone Marrow Neoplasms读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0187667<br><br> <br><br>书目名称Biology and Treatment of Leukemia and Bone Marrow Neoplasms读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0187667<br><br> <br><br>
猛击
发表于 2025-3-21 22:24:37
http://reply.papertrans.cn/19/1877/187667/187667_2.png
红润
发表于 2025-3-22 03:31:48
http://reply.papertrans.cn/19/1877/187667/187667_3.png
enchant
发表于 2025-3-22 05:17:09
https://doi.org/10.1007/978-3-658-17357-9-AHN. The clinical presentation of SM can range from indolent to advanced depending on extent of mast cell burden and genetic profile. In the case of indolent SM, the goal of treatment is to control mediator release-related effects as well as to reduce mast cell burden. In the case of SM-AHN, therap
加花粗鄙人
发表于 2025-3-22 12:03:47
http://reply.papertrans.cn/19/1877/187667/187667_5.png
摇曳的微光
发表于 2025-3-22 15:35:04
Systemic Mastocytosis: Advances in Diagnosis and Current Management,-AHN. The clinical presentation of SM can range from indolent to advanced depending on extent of mast cell burden and genetic profile. In the case of indolent SM, the goal of treatment is to control mediator release-related effects as well as to reduce mast cell burden. In the case of SM-AHN, therap
Fillet,Filet
发表于 2025-3-22 18:13:53
0927-3042 ment of leukemias and bone marrow malignancies. The book is of special interest for hematologists, oncologists, and cancer researchers; it is also of value for hematology trainees and medical students..978-3-030-78313-6978-3-030-78311-2Series ISSN 0927-3042 Series E-ISSN 2509-8497
失败主义者
发表于 2025-3-22 21:11:48
0927-3042 targets for leukemia therapy.Provides comprehensive coverage.This book provides a concise update on current understanding of the biology of acute and chronic leukemias and other bone marrow neoplasms, including myelodysplastic and myeloproliferative disorders, and explores new and emerging treatment
语源学
发表于 2025-3-23 01:45:51
https://doi.org/10.1007/978-3-662-53687-2ologic neoplasms have moved from traditional histology and immunophenotyping to integration of cytogenetic and genomic alterations. Using illustrative cases, this chapter provides an overview of the utility of using genomic data for prognostication as well as treatment decision-making for patients with bone marrow neoplasms.
Insatiable
发表于 2025-3-23 08:45:03
http://reply.papertrans.cn/19/1877/187667/187667_10.png